cytarabine has been researched along with Carcinoma, Non-Small Cell Lung in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.56) | 18.7374 |
| 1990's | 9 (50.00) | 18.2507 |
| 2000's | 4 (22.22) | 29.6817 |
| 2010's | 3 (16.67) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Adema, AD; Alexander, LE; Cho, JH; Chu, CK; Daft, JR; Hoebe, EK; Peters, GJ; Radi, M | 1 |
| Chen, M; Chen, X; Fang, F; Guo, J; Han, L; Hung, MC; Kuang, X; Li, H; Li, J; Liang, L; Liu, H; Liu, J; Ma, F; Peng, C; Su, J; Sun, L; Tao, J; Weng, L; Xie, Y; Xie, Z; Xu, X; Yang, N; Ye, Y; Zhang, J; Zhang, X; Zhang, Y; Zhao, S | 1 |
| Gwak, HS; Han, JY; Joo, J; Kim, HT; Kim, S; Lee, JS; Lee, SH; Shin, SH; Yoo, H | 1 |
| Bruheim, S; Fodstad, O; Mælandsmo, GM; Sandvold, ML | 1 |
| Aamdal, S; Dueland, S; Gaullier, JM; Lind, MJ; Rasch, W; Sandvold, ML; Thomas, H | 1 |
| Nagpal, S; Riess, J; Wakelee, H | 1 |
| Hasumi, T; Isogami, K; Kobayashi, S; Noda, M | 1 |
| Boivin, AJ; Gourdeau, H; Momparler, RL | 1 |
| Albeck, M; Bruderman, I; Catane, R; Gafter, U; Gal, R; Kalechman, Y; Kaufman, B; Mettinger, KL; Shani, A; Shapira, J; Sredni, B; Tichler, T; Whisnant, JK; Xu, RH | 1 |
| Alvord, WG; Gazdar, AF; Gray-Goodrich, M; Koo, HM; McWilliams, MJ; Mikheev, A; Monks, A; Oie, HK; Paull, KD; Rubinstein, LV; Vande Woude, GF; Zarbl, H | 1 |
| Tsukagoshi, S | 1 |
| Bible, KC; Kaufmann, SH | 1 |
| Chamberlain, MC; Cole, BF; Glantz, MJ; Howell, SB; Jaeckle, KA; LaFollette, S; Maria, B; Phuphanich, S; Recht, L; Schumann, GB; Swinnen, LJ | 1 |
| Bogden, AE; Carde, P; de Paillette, ED; Frindel, E; Moreau, JP; Tubiana, M | 1 |
| Atkins, JN; Craig, JB; Goldklang, GA; Jackson, DV; Muss, HB; Powell, BL; Richards, F; Schnell, FM; Stuart, RK; White, DR | 1 |
| Alvarez, LA; Bianco, A; Cuevas, MA; Leone, BA; Machiavelli, M; Perez, JE; Rabinovich, MG; Rodriguez, R; Romero, A; Vallejo, CT | 1 |
| Anderson, JR; Green, MR; Kramar, A; Richards, F; Schilsky, R; Skarin, A; Stoopler, M; Zimmer, B | 1 |
| Blijham, GH; Greve, LH; ten Velde, GP | 1 |
1 review(s) available for cytarabine and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
[Recent development of antitumor antimetabolites in Japan--cytosine arabinoside analogues].
Topics: Animals; Antimetabolites, Antineoplastic; Arabinonucleotides; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cytarabine; Cytidine Monophosphate; Deoxycytidine; Gemcitabine; Humans; Lung Neoplasms; Mice; Neoplasm Transplantation | 1997 |
4 trial(s) available for cytarabine and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Intravenous administration of CP-4055 (ELACYT) in patients with solid tumours. A Phase I study.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Cytarabine; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Melanoma; Middle Aged; Neoplasms; Ovarian Neoplasms | 2009 |
The protective role of the immunomodulator AS101 against chemotherapy-induced alopecia studies on human and animal models.
Topics: Alopecia; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cytarabine; Cytokines; Dinoprostone; Ethylenes; Female; Humans; Indomethacin; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Lung Neoplasms; Macrophages; Male; Rats; Rats, Sprague-Dawley; Sialoglycoproteins | 1996 |
A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Brain Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cytarabine; Delayed-Action Preparations; Disease Progression; Female; Humans; Injections, Spinal; Lung Neoplasms; Male; Melanoma; Meningeal Neoplasms; Methotrexate; Middle Aged; Neoplasms; Prospective Studies; Survival Rate; Survivors | 1999 |
Platinum-based combination chemotherapy in advanced non-small cell lung cancer: a randomized phase II trial of the Cancer and Leukemia Group B.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cytarabine; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Randomized Controlled Trials as Topic; Survival Rate; Vinblastine | 1990 |
13 other study(ies) available for cytarabine and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
In vitro optimization of non-small cell lung cancer activity with troxacitabine, L-1,3-dioxolane-cytidine, prodrugs.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cytosine; Dioxolanes; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; Prodrugs; Stereoisomerism; Structure-Activity Relationship | 2007 |
ADORA1 Inhibition Promotes Tumor Immune Evasion by Regulating the ATF3-PD-L1 Axis.
Topics: Activating Transcription Factor 3; Adenosine A1 Receptor Antagonists; Adult; Aged; Animals; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cytarabine; Female; Humans; Lomustine; Lung Neoplasms; Male; Melanoma; Mice, Inbred BALB C; Mice, Inbred C57BL; Middle Aged; Mitoxantrone; Prednisone; Receptor, Adenosine A1; Tumor Escape; Xenograft Model Antitumor Assays | 2020 |
Analysis of treatment outcomes of intraventricular chemotherapy in 105 patients for leptomeningeal carcinomatosis from non-small-cell lung cancer.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cranial Nerve Diseases; Cytarabine; Erlotinib Hydrochloride; Female; Gefitinib; Headache; Humans; Hydrocortisone; Infusions, Intraventricular; Intracranial Pressure; Karnofsky Performance Status; Lung Neoplasms; Male; Meningeal Carcinomatosis; Mental Disorders; Methotrexate; Middle Aged; Nausea; Palliative Care; Protein Kinase Inhibitors; Quinazolines; Retrospective Studies; Vomiting | 2013 |
Antitumor activity of elacytarabine combined with bevacizumab, cetuximab and trastuzumab in human NSCLC xenografts.
Topics: Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carcinoma, Non-Small-Cell Lung; Cetuximab; Cytarabine; Female; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Trastuzumab; Xenograft Model Antitumor Assays | 2013 |
Treatment of leptomeningeal spread of NSCLC: a continuing challenge.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Cytarabine; ErbB Receptors; Erlotinib Hydrochloride; Glutamates; Guanine; Humans; Meningeal Neoplasms; Methotrexate; Mutation; Pemetrexed; Quinazolines; Radiation Dosage | 2012 |
c-myc amplification and enhancement of sensitivity to cytosine arabinoside: an in vitro and in vivo study on four sublines established from a pulmonary adenocarcinoma.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Cell Division; Cytarabine; Drug Resistance, Neoplasm; Gene Amplification; Genes, myc; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Phenotype; Tumor Cells, Cultured | 2002 |
Action of troxacitabine on cells transduced with human cytidine deaminase cDNA.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cytarabine; Cytidine Deaminase; Cytosine; Dioxolanes; Drug Resistance, Neoplasm; Humans; Lung Neoplasms; Transduction, Genetic; Tumor Cells, Cultured | 2004 |
Enhanced sensitivity to 1-beta-D-arabinofuranosylcytosine and topoisomerase II inhibitors in tumor cell lines harboring activated ras oncogenes.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Colonic Neoplasms; Cytarabine; Daunorubicin; Deoxycytidine; DNA Mutational Analysis; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Gemcitabine; Gene Expression Regulation, Neoplastic; Genes, ras; Humans; Lung Neoplasms; Software; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1996 |
Cytotoxic synergy between flavopiridol (NSC 649890, L86-8275) and various antineoplastic agents: the importance of sequence of administration.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carmustine; Cisplatin; Cyclin-Dependent Kinases; Cytarabine; Doxorubicin; Drug Administration Schedule; Drug Synergism; Etoposide; Flavonoids; Fluorouracil; Humans; Lung Neoplasms; Paclitaxel; Piperidines; Tumor Stem Cell Assay | 1997 |
Amelioration of chemotherapy-induced toxicity by cotreatment with AcSDKP, a tetrapeptide inhibitor of hematopoietic stem cell proliferation.
Topics: Animals; Body Weight; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Line; Cyclophosphamide; Cytarabine; Female; Growth Inhibitors; Hematopoietic Stem Cells; Humans; Immunologic Deficiency Syndromes; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Oligopeptides; Transplantation, Heterologous | 1991 |
A phase II trial of high-dose cytarabine and cisplatin in previously untreated non-small cell carcinoma of the lung. A Piedmont Oncology Association Study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cytarabine; Drug Evaluation; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Remission Induction; Vomiting | 1990 |
Phase II trial of cytarabine, cisplatin and vindesine for advanced non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cytarabine; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Vindesine | 1990 |
Cisplatin and cytarabine combination chemotherapy of advanced non-small cell lung cancer: a pilot study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cytarabine; Humans; Lung Neoplasms; Middle Aged; Pilot Projects | 1987 |